To define the relationship between CXCR2 expression and the clinical prognosis of melanoma patients, we examined clinical data from the Cancer Genome Atlas (TCGA), and the skin cutaneous melanoma (SKCM) dataset using Gene Expression Profiling Interactive Analysis (GEPIA). This evidence concerns the gene CXCR2 and melanoma.